Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Clin Cancer Res. 2021 Mar 15;27(15):4177–4185. doi: 10.1158/1078-0432.CCR-20-2114

Figure 3.

Figure 3.

Progression-free survival by baseline mutation of (A) PIK3CA, (B) ESR1, and (C) PIK3CA and/or ESR1. MUT, mutated; PFS, progression-free survival; WT, wild type.